Lucas Ward
Stock Analyst at Ascendiant Capital
(n/a)
# 4,048
Out of 4,667 analysts
11
Total ratings
n/a
Success rate
-42.21%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HSCS HeartSciences | Reiterates: Buy | $15 | $2.64 | +468.18% | 1 | Sep 23, 2024 | |
| CYTH Cyclo Therapeutics | Maintains: Buy | $2.6 → $0.95 | $0.68 | +39.50% | 2 | Aug 26, 2024 | |
| LIQT LiqTech International | Reiterates: Buy | $5.15 | $1.73 | +197.69% | 2 | Aug 26, 2024 | |
| ACON Aclarion | Maintains: Buy | $1.6 → $1.5 | $0.18 | +749.86% | 2 | Aug 26, 2024 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $6.4 → $6.6 | $2.83 | +133.22% | 1 | Aug 20, 2024 | |
| VMAR Vision Marine Technologies | Maintains: Buy | $338 → $270 | $2.91 | +9,178.35% | 2 | Jul 29, 2024 | |
| SXTP 60 Degrees Pharmaceuticals | Initiates: Buy | $29 | $0.92 | +3,030.43% | 1 | Oct 2, 2023 |
HeartSciences
Sep 23, 2024
Reiterates: Buy
Price Target: $15
Current: $2.64
Upside: +468.18%
Cyclo Therapeutics
Aug 26, 2024
Maintains: Buy
Price Target: $2.6 → $0.95
Current: $0.68
Upside: +39.50%
LiqTech International
Aug 26, 2024
Reiterates: Buy
Price Target: $5.15
Current: $1.73
Upside: +197.69%
Aclarion
Aug 26, 2024
Maintains: Buy
Price Target: $1.6 → $1.5
Current: $0.18
Upside: +749.86%
Vivos Therapeutics
Aug 20, 2024
Maintains: Buy
Price Target: $6.4 → $6.6
Current: $2.83
Upside: +133.22%
Vision Marine Technologies
Jul 29, 2024
Maintains: Buy
Price Target: $338 → $270
Current: $2.91
Upside: +9,178.35%
60 Degrees Pharmaceuticals
Oct 2, 2023
Initiates: Buy
Price Target: $29
Current: $0.92
Upside: +3,030.43%